Intratechal Chemotherapy Treatment Through an Ommaya Reservoir Catheter for Meningeal Carcinomatosis: A Single-Centre Experience

Detalhes bibliográficos
Autor(a) principal: Lavrador, José Pedro
Data de Publicação: 2016
Outros Autores: Simas, Nuno, Oliveira, Edson, Carvalho, Manuel Herculano
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6733
Resumo: Introduction: Meningeal carcinomatosis is defined as tumour cells infiltration of leptomeninges and subarachnoid space. It is normally related with poor survival (2 - 5 months). The best multidisciplinary treatment for this condition is a matter of discussion. Patient’s condition and the natural history of the disease should be considered in the decision making process.Material and Methods: Retrospective cohort analysis of patients submitted to Ommaya Reservoir placement due to systemic solid tumour meningeal carcinomatosis between 2006 and 2014.Results: Twenty three patients were included (19 females, four males) with median age of 56.1 ± 2.2 years. The primary tumour was: breast – 16 patients, lung – four patients, stomach, bladder and cervix – one patient each. No complications were seen (infection, intracranial haematoma or CSF fistula). The median survival was 26.4 ± 7.7 weeks, range between nine days and 118 weeks (21/23 patients). Male gender was related to poor prognosis in crude analysis (p value = 0.0032). Breast adenocarcinoma was related with better prognosis in adjust analysis (p value = 0.036, HR: 4.36 ± 3.06; 95% IC: 1.10 - 17.25). Longer time between initial tumour and meningeal carcinomatosis diagnosis was related to a better outcome but without statistical significance.Discussion: Despite the low complication rate of Ommaya reservoir placement, the poor response to chemotherapy and the disease prognosis should be considered in patients with poor functional status. The relationship observed between the primary tumour and the overall survival supports that meningeal carcinomatosis should not be considered a disease by itself but always in the context of a systemic disease. The low incidence of breast cancer in male population might be related with it poorer prognosis.Conclusion: Meningeal carcinomatosis has a poor prognosis. Breast adenocarcinoma, longer time between initial tumour andmeningeal carcinomatosis diagnosis, and age < 60 years were related with longer survival.
id RCAP_afddb59bb102f9dbde037c58456c8395
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/6733
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Intratechal Chemotherapy Treatment Through an Ommaya Reservoir Catheter for Meningeal Carcinomatosis: A Single-Centre ExperienceTratamento de Carcinomatose Meníngea por Quimioterapia Intratecal Através de Catéter Reservatório de Ommaya: Experiência de um Centro NeurocirúrgicoInjectionsSpinalMeningeal Carcinomatosis/drug therapyNeoplasm Metastasis/drug therapyTreatment Outcome.Carcinomatose Meníngea/quimioterapiaInjecções EspinhaisMetástase Neoplásica/quimioterapiaResultado do Tratamento.Introduction: Meningeal carcinomatosis is defined as tumour cells infiltration of leptomeninges and subarachnoid space. It is normally related with poor survival (2 - 5 months). The best multidisciplinary treatment for this condition is a matter of discussion. Patient’s condition and the natural history of the disease should be considered in the decision making process.Material and Methods: Retrospective cohort analysis of patients submitted to Ommaya Reservoir placement due to systemic solid tumour meningeal carcinomatosis between 2006 and 2014.Results: Twenty three patients were included (19 females, four males) with median age of 56.1 ± 2.2 years. The primary tumour was: breast – 16 patients, lung – four patients, stomach, bladder and cervix – one patient each. No complications were seen (infection, intracranial haematoma or CSF fistula). The median survival was 26.4 ± 7.7 weeks, range between nine days and 118 weeks (21/23 patients). Male gender was related to poor prognosis in crude analysis (p value = 0.0032). Breast adenocarcinoma was related with better prognosis in adjust analysis (p value = 0.036, HR: 4.36 ± 3.06; 95% IC: 1.10 - 17.25). Longer time between initial tumour and meningeal carcinomatosis diagnosis was related to a better outcome but without statistical significance.Discussion: Despite the low complication rate of Ommaya reservoir placement, the poor response to chemotherapy and the disease prognosis should be considered in patients with poor functional status. The relationship observed between the primary tumour and the overall survival supports that meningeal carcinomatosis should not be considered a disease by itself but always in the context of a systemic disease. The low incidence of breast cancer in male population might be related with it poorer prognosis.Conclusion: Meningeal carcinomatosis has a poor prognosis. Breast adenocarcinoma, longer time between initial tumour andmeningeal carcinomatosis diagnosis, and age < 60 years were related with longer survival.Introdução: A carcinomatose meníngea consiste na infiltração de células tumorais ao longo das leptomeninges e espaço subaracnoideu, encontrando-se associada a uma sobrevida média de 2 - 5 meses. As indicações sobre a modalidade mais adequada de tratamento permanecem tema de discussão, sendo fundamental um correto conhecimento da história natural da doença e da dualidade risco-benefício para uma decisão terapêutica interdisciplinar.Material e Métodos: Análise retrospectiva dos doentes com diagnóstico de carcinomatose meníngea com origem em tumores sólidos submetidos a colocação de catéter reservatório de Ommaya no período entre 2006 a 2014 no Serviço de Neurocirurgia do Hospital Santa Maria.Resultados: Foram operados 23 doentes com carcinomatose meníngea (19 mulheres, quatro homens) com idade média de 56,1 ± 2,2 anos. A origem do tumor primário foi: mama – 16 doentes, pulmão – quatro doentes, estômago, bexiga e colo do útero – um doente cada. Não se verificaram complicações tais como infecção, hematomas intracranianos ou fístula de líquor. A sobrevida média dos 21 doentes falecidos à data foi de 26,4 ± 7,7 semanas (mínimo nove dias, máximo 118 semanas). A análise estatística não ajustada revelou que o sexo masculino esteve associado a pior prognóstico (p value = 0,0032), enquanto a análise ajustada mostrou que a origem na mama esteve associada a melhor prognóstico (p value = 0,036) quando comparada com as outras etiologias (HR: 4,36 ± 3,06; 95% IC: 1,10 - 17,25). Um maior tempo de evolução de doença primária até ao diagnóstico esteve associado a melhor prognóstico, apesar de não ter atingido significado estatístico.Discussão: Apesar da colocação de catéter reservatório de Ommaya ser um procedimento com baixo risco de complicações, a resposta à quimioterapia intratecal é limitada e o prognóstico da doença poderá não justificar um procedimento cirúrgico num doente com mau estado funcional. A relação da sobrevida global com a origem do tumor primário sugere que o prognóstico da carcinomatose meníngea deve ser considerado no contexto da doença sistémica e não como uma doença isolada. O pior prognóstico do sexo masculino pode justificar-se pela menor incidência do tumor da mama neste género.Conclusão: A carcinomatose meníngea está associada a um mau prognóstico. Origem primária na mama, maior tempo de evolução de doença primária e idade < 60 anos estiveram associados a sobrevida mais longa.Ordem dos Médicos2016-08-31info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6733oai:ojs.www.actamedicaportuguesa.com:article/6733Acta Médica Portuguesa; Vol. 29 No. 7-8 (2016): July-August; 456-460Acta Médica Portuguesa; Vol. 29 N.º 7-8 (2016): Julho-Agosto; 456-4601646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6733https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6733/4731https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6733/8652Direitos de Autor (c) 2016 Acta Médica Portuguesainfo:eu-repo/semantics/openAccessLavrador, José PedroSimas, NunoOliveira, EdsonCarvalho, Manuel Herculano2022-12-20T11:04:58Zoai:ojs.www.actamedicaportuguesa.com:article/6733Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:19:21.529318Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Intratechal Chemotherapy Treatment Through an Ommaya Reservoir Catheter for Meningeal Carcinomatosis: A Single-Centre Experience
Tratamento de Carcinomatose Meníngea por Quimioterapia Intratecal Através de Catéter Reservatório de Ommaya: Experiência de um Centro Neurocirúrgico
title Intratechal Chemotherapy Treatment Through an Ommaya Reservoir Catheter for Meningeal Carcinomatosis: A Single-Centre Experience
spellingShingle Intratechal Chemotherapy Treatment Through an Ommaya Reservoir Catheter for Meningeal Carcinomatosis: A Single-Centre Experience
Lavrador, José Pedro
Injections
Spinal
Meningeal Carcinomatosis/drug therapy
Neoplasm Metastasis/drug therapy
Treatment Outcome.
Carcinomatose Meníngea/quimioterapia
Injecções Espinhais
Metástase Neoplásica/quimioterapia
Resultado do Tratamento.
title_short Intratechal Chemotherapy Treatment Through an Ommaya Reservoir Catheter for Meningeal Carcinomatosis: A Single-Centre Experience
title_full Intratechal Chemotherapy Treatment Through an Ommaya Reservoir Catheter for Meningeal Carcinomatosis: A Single-Centre Experience
title_fullStr Intratechal Chemotherapy Treatment Through an Ommaya Reservoir Catheter for Meningeal Carcinomatosis: A Single-Centre Experience
title_full_unstemmed Intratechal Chemotherapy Treatment Through an Ommaya Reservoir Catheter for Meningeal Carcinomatosis: A Single-Centre Experience
title_sort Intratechal Chemotherapy Treatment Through an Ommaya Reservoir Catheter for Meningeal Carcinomatosis: A Single-Centre Experience
author Lavrador, José Pedro
author_facet Lavrador, José Pedro
Simas, Nuno
Oliveira, Edson
Carvalho, Manuel Herculano
author_role author
author2 Simas, Nuno
Oliveira, Edson
Carvalho, Manuel Herculano
author2_role author
author
author
dc.contributor.author.fl_str_mv Lavrador, José Pedro
Simas, Nuno
Oliveira, Edson
Carvalho, Manuel Herculano
dc.subject.por.fl_str_mv Injections
Spinal
Meningeal Carcinomatosis/drug therapy
Neoplasm Metastasis/drug therapy
Treatment Outcome.
Carcinomatose Meníngea/quimioterapia
Injecções Espinhais
Metástase Neoplásica/quimioterapia
Resultado do Tratamento.
topic Injections
Spinal
Meningeal Carcinomatosis/drug therapy
Neoplasm Metastasis/drug therapy
Treatment Outcome.
Carcinomatose Meníngea/quimioterapia
Injecções Espinhais
Metástase Neoplásica/quimioterapia
Resultado do Tratamento.
description Introduction: Meningeal carcinomatosis is defined as tumour cells infiltration of leptomeninges and subarachnoid space. It is normally related with poor survival (2 - 5 months). The best multidisciplinary treatment for this condition is a matter of discussion. Patient’s condition and the natural history of the disease should be considered in the decision making process.Material and Methods: Retrospective cohort analysis of patients submitted to Ommaya Reservoir placement due to systemic solid tumour meningeal carcinomatosis between 2006 and 2014.Results: Twenty three patients were included (19 females, four males) with median age of 56.1 ± 2.2 years. The primary tumour was: breast – 16 patients, lung – four patients, stomach, bladder and cervix – one patient each. No complications were seen (infection, intracranial haematoma or CSF fistula). The median survival was 26.4 ± 7.7 weeks, range between nine days and 118 weeks (21/23 patients). Male gender was related to poor prognosis in crude analysis (p value = 0.0032). Breast adenocarcinoma was related with better prognosis in adjust analysis (p value = 0.036, HR: 4.36 ± 3.06; 95% IC: 1.10 - 17.25). Longer time between initial tumour and meningeal carcinomatosis diagnosis was related to a better outcome but without statistical significance.Discussion: Despite the low complication rate of Ommaya reservoir placement, the poor response to chemotherapy and the disease prognosis should be considered in patients with poor functional status. The relationship observed between the primary tumour and the overall survival supports that meningeal carcinomatosis should not be considered a disease by itself but always in the context of a systemic disease. The low incidence of breast cancer in male population might be related with it poorer prognosis.Conclusion: Meningeal carcinomatosis has a poor prognosis. Breast adenocarcinoma, longer time between initial tumour andmeningeal carcinomatosis diagnosis, and age < 60 years were related with longer survival.
publishDate 2016
dc.date.none.fl_str_mv 2016-08-31
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6733
oai:ojs.www.actamedicaportuguesa.com:article/6733
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6733
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/6733
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6733
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6733/4731
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6733/8652
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2016 Acta Médica Portuguesa
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2016 Acta Médica Portuguesa
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 29 No. 7-8 (2016): July-August; 456-460
Acta Médica Portuguesa; Vol. 29 N.º 7-8 (2016): Julho-Agosto; 456-460
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130644774649856